Alkermes
Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
Flexible Media Releases
Campaigns
Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that...
We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new...
We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid...
We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with...
We strive to have a positive impact on our employees, members of our communities, our local environment and society at large. We support research...
Since 2016, the Alkermes Inspiration Grants ® program has awarded more than $4 million in funding to innovative programs that support the...
